ARCHIVES

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

This article is from The Cancer Letter archive.

Vol. 20 No. 38 | October 7, 1994

Download PDF Visit The Full Archive

Related Articles

NIH Review Division Considering Proposal For Clinical Oncology Study Section

October 10, 1997

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs.

April 30, 2004

FDA Approves Molecular Test For Breast Cancer Detection

July 27, 2007

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Kidney, Bladder Cancer Causes, Treatment, Need More Research, NCI Advisors Find

July 26, 2002